This week (16th-20th), MNC Solutions, considered the last 'big fish' in this year's initial public offering (IPO) market, will be listed on the KOSPI market. Vect, Oncocross, and Onconic Therapeutics will also enter the KOSDAQ market.
According to the financial investment industry on the 15th, MNC Solutions will begin its first transaction on the KOSPI market on the 16th. The IPO process has seen lackluster performance, as there have been suggestions that the corporate value has been overestimated.
MNC Solutions set its offering price at 65,000 won, which is 19% lower than the lower end of its desired price range (80,000-93,300 won), as the competition ratio in the demand forecasting for institutional investors was only 8.18 to 1. The unified competition ratio in the subscription for general investors also reached just 2.4 to 1.
MNC Solutions was established through a spin-off of the defense business sector of Motrol, a former affiliate of the Doosan Group. Based on hydraulic motor technology, it supplies turret drive devices and others. The driving device from MNC Solutions is also used in the K9 self-propelled howitzer.
Vect, an electronic advertising board company, will also be listed on the KOSDAQ market on the 16th. Unlike MNC Solutions, Vect succeeded in its IPO process. Vect confirmed its offering price at the upper end of its desired offering price range (3,500-3,900 won), at 3,900 won. In the general subscription, it recorded a competition ratio of 1,170.34 to 1.
On the 18th, Oncocross, an AI new drug platform company, and Onconic Therapeutics, a bio company, will begin their first transactions on the KOSDAQ market on the 19th. Both companies set their offering prices below the lower end of their desired offering price ranges. The final offering price is 7,300 won for Oncocross and 13,000 won for Onconic Therapeutics.
Oncocross presented a low offering price, resulting in a successful general subscription with a unified competition ratio of 1,312.94 to 1. Onconic Therapeutics had a unified competition ratio of 91.88 to 1.
The subscription for general investors will also be conducted. Three A Logics will accept general subscriptions until the 16th. The offering price for Three A Logics is 11,000 won, and the underwriters are Shinhan Investment Corp. and Mirae Asset Securities. Fine Medics will conduct general subscriptions from the 16th to the 17th. The offering price for Fine Medics is 10,000 won, and Korea Investment & Securities is in charge.